Overview
Over the five years to 2015, the global Pharmaceutical industry has experienced moderate growth. Underpinning this growth has been rising demand for healthcare and medications worldwide, especially from emerging economies. In this context, Finglobedirect, which has been providing company and financial information globally since two decades, brings out an analytical report - Global Pharmaceuticals Business: Recent Growth and New Directions.

Objective
The objective of this report is to review and analyze the performance of the global pharmaceutical companies during the most recent 12 months based on financial data, business news, stock market returns, and other non-financial information not quantifiable.

Research Sources
Our research team has compiled financial information of global pharmaceutical companies throughout the year from reliable primary and secondary sources including company websites, press releases, and stock exchanges. Further, the business news have been compiled throughout the year from established news portals, regional and international primary news sources, business media sites, company websites and stock exchanges. Also, stock prices from global stock exchanges have been compiled to list out the top gainers/decliners of the year.

• Provides quarterly update with rolling 12 months of data to facilitate focused analysis
• Identifies the leading global pharmaceutical companies of most recent 12 months based on financial performance
• Identifies the leading global pharmaceutical companies of most recent 12 months based on type of business news
• Presents the top gainers and bottom decliners of most recent 12 months on the basis of comparative stock analysis
• Identifies capstone 100 global pharmaceutical companies of most recent 12 months based on analysis done by various attributes
• Identifies the leading products and brands of most recent 12 months for global pharmaceutical sector
• Presents the key policy implications and regulatory developments taken place in most recent 12 months in the global pharmaceutical sector

• 1.1.1: Top 100 fastest growing pharmaceutical companies
• 1.1.2: Top 100 most profitable pharmaceutical companies
• 1.1.3: Top 100 most efficient pharmaceutical companies
• 1.1.4: Top 100 most improved pharmaceutical companies

• 1.2.1: Leading 100 companies with major contracts/deals signed
• 1.2.2: Leading 100 companies with major mergers/acquisitions
• 1.2.3: Leading 100 companies with major expansions
• 1.2.4: Leading 100 companies with major joint ventures
• 1.2.5: Leading 100 companies with major innovations/R&D and product launches
• 1.2.6: Leading 100 companies with major management changes
• 1.2.7: Leading 100 companies with major future investments planned for coming years

• 1.3.1: Top 100 gainers/decliners each based on stock price changes compared to previous 12 months

• 3.1: Leading 100 multinational pharmaceutical companies in news
• 3.2: Leading 100 listed pharmaceutical companies in news
• 3.3: Leading 100 privately owned pharmaceutical companies in news
• 3.4: Leading 100 companies in news by sub industries
• 3.5: Leading 100 pharmaceutical companies with biotech or medical device companies investment ties

• 4.1: Major 100 products with regulatory approvals received
• 4.2: Major 100 global brands in news in pharmaceutical sector
• 4.3: Major 100 patents filed by global pharmaceutical companies in year
• 4.4: Major 100 patients’ studies in works as of December 31

• 5.1: Leading 10 countries with most mergers and acquisitions
• 5.2: Leading 10 countries with most research and development
• 5.3: Leading 10 countries with most expansions
• 5.4: Leading 10 countries where regulatory approvals have been very strict

• Appendix 1: Major 100 products with multiple manufacturers in global pharmaceutical sector (generic vs brand names)
• Appendix 2: Major 100 R&D centers of global pharmaceutical companies
• Appendix 3: Major 100 distributors worldwide of global pharmaceutical products
• Appendix 4: Major 100 suppliers of global pharmaceutical industry
• Appendix 5: Major 100 buyers of global pharmaceutical industry
• Appendix 6: Major 100 advertisers of global pharmaceutical sector
• Appendix 7: Major 100 PR/IR agencies of global pharmaceutical companies
• Appendix 8: Major 100 medical advisory boards of global pharmaceutical companies

• Company analysts with years of experience have analyzed the global pharmaceutical companies
• In-depth review and analysis of global pharmaceutical companies by various attributes
• An efficient process wherein same companies emerging as leading by various attributes are highlighted
• Reveals the leaders in the global pharmaceutical sector for most recent 12 months

Research Report: Global Pharma Business: Recent Growth and New Directions: $500

Select Product Global Pharmaceuticals Business: Recent Growth and New Directions

Select Price $500

$950 for all three publications: Global Pharmaceuticals Business series on Analysis/Investors Presentations (savings of $250)

• Global Pharmaceuticals Business: Recent Growth and New Directions $500
• Global Pharmaceuticals 500: Analysis of Quarterly Earnings (3rd Quarter 2015) $400
• Global Pharmaceuticals: Investor Presentations $295

Select Product Global Pharmaceuticals Business series on Analysis/Investors Presentations

Select Price $950

Please send us an email for any further queries to info@finglobedirect.com.